Stock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions

Stock Track

2024/11/10

Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.

MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.

Following the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/1189305993"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1189305993\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1189305993?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-11-10 23:46","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1189305993","market":"us","top_or_hot":-1,"title":"Stock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions","media":"Stock Track","content":"<p>Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.</p>\n\n<p>MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.</p>\n\n<p>Following the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | MindMed Shares Soar on Upbeat Earnings and Bullish Analyst Actions\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time smaller\">2024-11-10 23:46</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.</p>\n\n<p>MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.</p>\n\n<p>Following the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.</p>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"MNMD","symbol_name":"Mind Medicine (MindMed) Inc.","start_time":0,"source_url":"","article_id":"1189305993","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1189305993","pubTimestamp":1731253592,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Mind Medicine  Inc.  surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.MindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's perf","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"MNMD":"Mind Medicine (MindMed) Inc."},"translate_title":"股票追踪MindMed股价因乐观的盈利和看涨的分析师行动而飙升","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MNMD":1},"content_text":"Shares of Mind Medicine (MindMed) Inc. (MNMD) surged by a remarkable 21.01% on Thursday, November 8th, driven by the company's better-than-expected quarterly results and bullish actions from analysts.\nMindMed, a leading player in the emerging field of psychedelic drug development, reported an adjusted loss of $0.27 per share for the quarter ended September 30. This figure came in narrower than analysts' expectations of a $0.28 per share loss, surprising investors and sparking enthusiasm about the company's performance.\nFollowing the earnings release, several analysts raised their price targets and ratings on MindMed, further fueling the stock's rally. Canaccord Genuity boosted its price target to $16 from $14, while maintaining a Buy rating on the shares. Similarly, RBC Capital Markets increased its target to $21 from $20, also reiterating its Outperform rating.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}